May 14, 2013, 06.10 PM | Source: CNBC-TV18
One can hold Dr Reddys Laboratories, says Prakash Diwan, Chief Portfolio Strategist of Prakash Diwan's Wealth Circle, ECR.
Prakash Diwan (more)
Market Expert, prakashdiwan.in | Capital Expertise: Equity - Fundamental
He further added, "The best point is the valuations, I don’t think valuations are stretched as compared to Sun Pharma or a Cipla or a Lupin relatively. I think the investor should hold on. Wait for another 20-25 percent of an upside in the next 9 to 12 months if the investor is patient enough."
KRChoksey is bullish on Dr. Reddy’s Laboratories
Religare is bearish on Dr Reddys has recommended s
The fall in revenue and profits in the first quart
The letter has resulted in a delay of some of impo